Literature DB >> 21997720

18F-FDG PET to identify soft tissue disease in multiple myeloma.

Sharon F Hain1, Sobia Khan, William Stevenson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21997720     DOI： 10.1007/s00259-011-1957-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

1.  Diagnostic utility of FDG PET in multiple myeloma.

Authors:  Hossein Jadvar; Peter S Conti
Journal:  Skeletal Radiol       Date:  2002-09-26       Impact factor: 2.199

2.  Initial results in the assessment of multiple myeloma using 18F-FDG PET.

Authors:  H Schirrmeister; M Bommer; A K Buck; S Müller; P Messer; D Bunjes; H Döhner; L Bergmann; S N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03       Impact factor: 9.236

3.  Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma.

Authors:  K Detweiler Short; S V Rajkumar; D Larson; F Buadi; S Hayman; A Dispenzieri; M Gertz; S Kumar; J Mikhael; V Roy; R A Kyle; M Q Lacy
Journal:  Leukemia       Date:  2011-02-25       Impact factor: 11.528

Review 4.  Imaging of extraosseous myeloma: CT, PET/CT, and MRI features.

Authors:  Matthew N Hall; Jyothi P Jagannathan; Nikhil H Ramaiya; Atul B Shinagare; Annick D Van den Abbeele
Journal:  AJR Am J Roentgenol       Date:  2010-11       Impact factor: 3.959
  4 in total
  1 in total

1.  Whole-body MRI and PET/CT in multiple myeloma patients during staging and after treatment: personal experience in a longitudinal study.

Authors:  Giuseppe Lucio Cascini; Carmela Falcone; Domenico Console; Antonino Restuccia; Marco Rossi; Antonello Parlati; Oscar Tamburrini
Journal:  Radiol Med       Date:  2013-06-26       Impact factor: 3.469
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.